Drug Database
Back to search

Poland· PL-100007358

Arechin

A chloroquine product containing chloroquini phosphas, registered in Poland by Adamed Pharma S.A.. The same ATC class is registered in 7 of our 19 countries.

ATC P01BA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedArechinATCP01BA01REGISTER NO.PL-100007358PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chloroquini phosphasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chloroquine is registered in 7 of 19 countries.

Countries holding a registration under ATC P01BA01 (chloroquine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search chloroquine products by name

Chloroquine · ATC P01BA01

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of chloroquine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Chloroquine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • FR France$1.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Chloroquini phosphas
Manufacturer
Adamed Pharma S.A.
Country
Poland (PL)
ATC code
P01BA01
ATC class
Chloroquine
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990061914
  • gtin
    05909991139582

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

557 interactions on record for chloroquine.

Graded by severity as the source publishes them — 221 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chloroquine against other medicinesHow interaction checks work

Chloroquine · interactions on record

557 records

  • 221 severe
  • 306 moderate
  • 14 minor
  • 16 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chloroquine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chloroquine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Cyprus · Chloroquine Phosphate Remedica
  • Spain · Resochín
  • United Kingdom (Northern Ireland) · Avloclor, Chloroquine Phosphate Bristol Laboratories
  • Greece · Unikinon
  • Hungary · Delagil
  • Netherlands · A-Cq 100
  • Portugal · Cloroquina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1a8d11af-dd4e-4078-8af8-24139523a907
GET /v1/drugs/1a8d11af-dd4e-4078-8af8-24139523a907?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "250 mg",
  "packaging": "05909990061914 ¦ Rp ¦ 1116\n30 tabl. w fiolce\n05909991139582 ¦ Rp ¦ 91750\n30 tabl. w blistrze",
  "substance": "Chloroquini phosphas 250 mg",
  "common_name": "Chloroquini phosphas",
  "pl_product_id": "100007358",
  "pozwolenie_nr": "00619",
  "auth_procedure": "NAR",
  "authorisation_validity": "2026-04-30"
}
API referenceMCP serverPlans

See everything about chloroquine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console